v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Nonrelated Party
Preferred stock
Common stock
Common stock
Nonrelated Party
Additional paid-in Capital
Additional paid-in Capital
Nonrelated Party
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     2,369,797            
Beginning balance at Dec. 31, 2024 $ 754,383   $ 0 $ 2   $ 2,556,095   $ 468 $ (1,802,182)
Beginning balance (in shares) at Dec. 31, 2024       22,004,679          
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under equity plans (in shares)       183,037          
Issuance of common stock under equity plans 8,640         8,640      
Stock-based compensation expense related to equity-classified awards 20,931         20,931      
Other comprehensive income (loss) (79)             (79)  
Net loss (73,238)               (73,238)
Ending balance (in shares) at Mar. 31, 2025     2,369,797            
Ending balance at Mar. 31, 2025 710,637   $ 0 $ 2   2,585,666   389 (1,875,420)
Ending balance (in shares) at Mar. 31, 2025       22,187,716          
Beginning balance (in shares) at Dec. 31, 2024     2,369,797            
Beginning balance at Dec. 31, 2024 754,383   $ 0 $ 2   2,556,095   468 (1,802,182)
Beginning balance (in shares) at Dec. 31, 2024       22,004,679          
Increase (Decrease) in Stockholders' Equity                  
Other comprehensive income (loss) 643                
Net loss (115,519)                
Ending balance (in shares) at Jun. 30, 2025     2,369,797            
Ending balance at Jun. 30, 2025 695,978   $ 0 $ 2   2,612,566   1,111 (1,917,701)
Ending balance (in shares) at Jun. 30, 2025       22,221,116          
Beginning balance (in shares) at Mar. 31, 2025     2,369,797            
Beginning balance at Mar. 31, 2025 710,637   $ 0 $ 2   2,585,666   389 (1,875,420)
Beginning balance (in shares) at Mar. 31, 2025       22,187,716          
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under equity plans (in shares)         33,400        
Issuance of common stock under equity plans   $ 1,741         $ 1,741    
Stock-based compensation expense related to equity-classified awards 25,159         25,159      
Other comprehensive income (loss) 722             722  
Net loss (42,281)               (42,281)
Ending balance (in shares) at Jun. 30, 2025     2,369,797            
Ending balance at Jun. 30, 2025 $ 695,978   $ 0 $ 2   2,612,566   1,111 (1,917,701)
Ending balance (in shares) at Jun. 30, 2025       22,221,116          
Beginning balance (in shares) at Dec. 31, 2025 2,369,797   2,369,797            
Beginning balance at Dec. 31, 2025 $ 602,689   $ 0 $ 2   2,692,280   873 (2,090,466)
Beginning balance (in shares) at Dec. 31, 2025 22,842,073     22,842,073          
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under equity plans (in shares)       199,845          
Issuance of common stock under equity plans $ 2,329         2,329      
Stock-based compensation expense related to equity-classified awards 32,618         32,618      
Other comprehensive income (loss) 209             209  
Net loss (94,391)               (94,391)
Ending balance (in shares) at Mar. 31, 2026     2,369,797            
Ending balance at Mar. 31, 2026 $ 543,454   $ 0 $ 2   2,727,227   1,082 (2,184,857)
Ending balance (in shares) at Mar. 31, 2026       23,041,918          
Beginning balance (in shares) at Dec. 31, 2025 2,369,797   2,369,797            
Beginning balance at Dec. 31, 2025 $ 602,689   $ 0 $ 2   2,692,280   873 (2,090,466)
Beginning balance (in shares) at Dec. 31, 2025 22,842,073     22,842,073          
Increase (Decrease) in Stockholders' Equity                  
Other comprehensive income (loss) $ (65)                
Net loss $ (152,330)                
Ending balance (in shares) at Jun. 30, 2026 2,369,797   2,369,797            
Ending balance at Jun. 30, 2026 $ 523,724   $ 0 $ 2   2,765,710   808 (2,242,796)
Ending balance (in shares) at Jun. 30, 2026 23,093,974     23,093,974          
Beginning balance (in shares) at Mar. 31, 2026     2,369,797            
Beginning balance at Mar. 31, 2026 $ 543,454   $ 0 $ 2   2,727,227   1,082 (2,184,857)
Beginning balance (in shares) at Mar. 31, 2026       23,041,918          
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under equity plans (in shares)       52,056          
Issuance of common stock under equity plans 3,112         3,112      
Stock-based compensation expense related to equity-classified awards 35,371         35,371      
Other comprehensive income (loss) (274)             (274)  
Net loss $ (57,939)               (57,939)
Ending balance (in shares) at Jun. 30, 2026 2,369,797   2,369,797            
Ending balance at Jun. 30, 2026 $ 523,724   $ 0 $ 2   $ 2,765,710   $ 808 $ (2,242,796)
Ending balance (in shares) at Jun. 30, 2026 23,093,974     23,093,974